CLV in Action: Allergan Aesthetics Found $1B in Untapped Customer Lifetime Value
This case-study based webinar will investigate the best practices followed by Allergan Aesthetics in analyzing and activating CLV across their B2B2C business model, where they have identified $1B in additional CLV and have now embedded this critical metric into the core operations of their business.
Tuesday, April 17 at 11:00 am EST
Pete and Alex we’ll dive into:
- The business drivers that led Allergan Aesthetics to pursue a deeper understanding of customer value and the cross-functional effort implemented to ensure success
- How they approached the analysis – examining two critical parts of the revenue model, the healthcare providers and the end consumer
- Reflections on the challenges and learnings
- How they have embedded CLV across the organization to ensure a sustained customer-centric focus to growth
- The shifts the organization has made in their DTC marketing as well as how they support various stakeholders in this B2B2C business model
Register below.
Who Is Alex Topacio?
Alex leads Pricing, Analytics, and Personalization for Allergan Data Labs. In this role, Alex is focused on using data to drive more effective commercial strategies, targeted consumer and provider engagement, and performance measurement for Allergan Aesthetics in the US. He is particularly focused on driving improved patient retention and cross-selling of the Allergan Aesthetics portfolio.
Prior to joining Allergan Data Labs, Alex was a Project Leader at Boston Consulting Group, where he led consulting engagements for clients in the biopharmaceutical and medical device industries on topics including strategy, organizational design, and digital innovation.